Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib

Lung carcinoma is the leading cause of death by cancer in the world. Nowadays, most patients will experience disease progression during or after first-line chemotherapy demonstrating the need for new, effective second-line treatments. The only approved second-line therapies for patients without targ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Med (Lausanne)
Main Authors: Corrales, Luis, Nogueira, Amanda, Passiglia, Francesco, Listi, Angela, Caglevic, Christian, Giallombardo, Marco, Raez, Luis, Santos, Edgardo, Rolfo, Christian
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2017
Assuntos:
Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5329017/
https://ncbi.nlm.nih.gov/pubmed/28293555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2017.00013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados